An innovative enterprise dedicated to the research and development, production, and sales of RNA molecular diagnostic technology and products. Since its establishment, the company has been committed to researching and promoting RNA molecular diagnostic reagents and supporting automation equipment based on the RNA real-time fluorescence constant temperature amplification (SAT) technology platform.

Compared with DNA molecular diagnostic technology (PCR), SAT technology has the characteristics of high sensitivity, strong specificity, low cross contamination, and easy implementation of fully automated high-throughput detection. It can be widely applied in various fields such as clinical testing, blood screening, food safety testing, emergency prevention and control of infectious diseases, and rapid response.